Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Tuunanen

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Circulation|November 8, 2006
Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failureHelena Tuunanen, Erik Engblom, Alexandru Naum, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 29, 2008
The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humansSara Rigazio, Hanna-Riikka Lehto, Helena Tuunanen, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 9, 2007
Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography studyHelena Tuunanen, Johanna Kuusisto, Jyri Toikka, et al.
Circulation|September 4, 2008
Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathyHelena Tuunanen, Erik Engblom, Alexandru Naum, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 21, 2011
Human obesity is characterized by defective fat storage and enhanced muscle fatty acid oxidation, and trimetazidine gradually counteracts these abnormalitiesMarco Bucci, Ronald Borra, Kjell Någren, et al.
Cardiovascular Therapeutics|September 3, 2011
Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humansMarco Bucci, Ronald Borra, Kjell Någren, et al.
International Journal of Cardiology. Heart & Vasculature|November 7, 2024
Economic burden of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in FinlandMarkku Pentikäinen, Piia Simonen, Pauliina Leskelä, et al.
Frontiers in Physiology|February 25, 2012
Cardiac Function, Perfusion, Metabolism, and Innervation following Autologous Stem Cell Therapy for Acute ST-Elevation Myocardial Infarction. A FINCELL-INSIGHT Sub-Study with PET and MRIMaija T Mäki, Juha W Koskenvuo, Heikki Ukkonen, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Circulation|November 8, 2006
Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failureHelena Tuunanen, Erik Engblom, Alexandru Naum, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 29, 2008
The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humansSara Rigazio, Hanna-Riikka Lehto, Helena Tuunanen, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 9, 2007
Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography studyHelena Tuunanen, Johanna Kuusisto, Jyri Toikka, et al.
Circulation|September 4, 2008
Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathyHelena Tuunanen, Erik Engblom, Alexandru Naum, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 21, 2011
Human obesity is characterized by defective fat storage and enhanced muscle fatty acid oxidation, and trimetazidine gradually counteracts these abnormalitiesMarco Bucci, Ronald Borra, Kjell Någren, et al.
Cardiovascular Therapeutics|September 3, 2011
Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humansMarco Bucci, Ronald Borra, Kjell Någren, et al.
International Journal of Cardiology. Heart & Vasculature|November 7, 2024
Economic burden of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in FinlandMarkku Pentikäinen, Piia Simonen, Pauliina Leskelä, et al.
Frontiers in Physiology|February 25, 2012
Cardiac Function, Perfusion, Metabolism, and Innervation following Autologous Stem Cell Therapy for Acute ST-Elevation Myocardial Infarction. A FINCELL-INSIGHT Sub-Study with PET and MRIMaija T Mäki, Juha W Koskenvuo, Heikki Ukkonen, et al.
Pageof 2